brain tumor, recurrent
Showing 1 - 20 of 20
Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)
Not yet recruiting
- Primary Brain Tumor
- Brain Tumor, Recurrent
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022
Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )
Not yet recruiting
- Glioblastoma
- +3 more
- Sativex
- +2 more
-
Belfast, United Kingdom
- +14 more
Nov 29, 2022
Vegetative Monitoring During Brainstem-associated Surgery
Completed
- Brain Tumor, Recurrent
- +3 more
- Intraoperative Monitoring during resection of brain tumor
-
Tübingen, GermanyDepartment of Neurosurgery
Nov 3, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)
Active, not recruiting
- Malignant Glioma
- Brain Tumor, Recurrent
-
Durham, North CarolinaPreston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)
Recruiting
- Brain Tumor, Recurrent
- Brain Tumor, Refractory
- HER2-specific T cells
-
Houston, Texas
- +1 more
May 3, 2022
GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)
Active, not recruiting
- GBM
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Jan 23, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor Trial in Cleveland (AutoLITT system)
Completed
- Brain Tumor
- +5 more
- AutoLITT system
-
Cleveland, Ohio
- +1 more
Aug 23, 2021
Glioblastoma, Brain Tumor, Recurrent Trial in Spain (PF-299804 (Dacomitinib))
Completed
- Glioblastoma
- Brain Tumor, Recurrent
- PF-299804 (Dacomitinib)
-
Badalona, Barcelona, Spain
- +11 more
Jul 2, 2021
Brain Tumor, Primary, Brain Tumor, Recurrent Trial (Indocyanine Green)
Completed
- Brain Tumor, Primary
- Brain Tumor, Recurrent
- Indocyanine Green
- (no location specified)
Aug 13, 2020
Brain Tumor, Recurrent Trial in Wauwatosa (Photofrin (porfimer sodium) & photodynamic therapy.)
Completed
- Brain Tumor, Recurrent
- Photofrin (porfimer sodium) & photodynamic therapy.
-
Wauwatosa, WisconsinChildren's Hospital of Wisconsin
Feb 21, 2019
Surgery, Brain Tumor, Brain Tumor, Recurrent Trial in London (Transitional Care Programme)
Unknown status
- Surgery
- +21 more
- Transitional Care Programme
-
London, United KingdomBart's Health NHS Trust
Jul 10, 2018
Benign Tumors, Brain, Brain Cancer, Brain Tumors, Benign Trial in United States (5-ALA (Gliolan))
Withdrawn
- Benign Neoplasms, Brain
- +14 more
- 5-ALA (Gliolan)
-
Atlanta, Georgia
- +5 more
May 13, 2016
Brain Tumor, Recurrent, Glioblastoma Multiforme Trial in Chicago (Photon Radiosurgery System (Intrabeam))
Completed
- Brain Tumor, Recurrent
- Glioblastoma Multiforme
- Photon Radiosurgery System (Intrabeam)
-
Chicago, IllinoisChildren's Memorial Hospital
Feb 27, 2015
Wilms Tumor, Fibrosarcoma, Carcinoma, Round Cell Trial in Ann Arbor (Myeloablative Chemotherapy, Stem Cell Rescue)
Completed
- Wilms Tumor
- +4 more
- Myeloablative Chemotherapy
- Stem Cell Rescue
-
Ann Arbor, MichiganThe University of Michigan
May 19, 2014
Glioblastoma, Astrocytoma, Oligodendroglioma Trial in Istanbul (Temozolomide)
Completed
- Glioblastoma
- +3 more
-
Istanbul, TurkeyMarmara University Hospital
Nov 3, 2013